共 279 条
[1]
Roodman GD(2005)Paget disease of bone J Clin Invest. 115 200-8
[2]
Windle JJ(1992)Interleukin 6. A potential autocrine/paracrine factor in Paget’s disease of bone J Clin Invest. 89 46-52
[3]
Roodman GD(2014)Pathobiology of Paget’s disease of bone J Bone Metab. 21 85-98
[4]
Kurihara N(2014)Increased IL-6 expression in osteoclasts is necessary but not sufficient for the development of Paget’s disease of bone J Bone Miner Res. 29 1456-65
[5]
Ohsaki Y(2017)Durability of response to zoledronate treatment and competing mortality in Paget’s disease of bone J Bone Miner Res. 32 753-6
[6]
Kukita A(2022)The osteocyte as a signaling cell Physiol Rev. 102 379-410
[7]
Hosking D(2022)Update on the pathogenesis and genetics of Paget’s disease of bone Front Cell Dev Biol. 10 932065-44
[8]
Demulder A(2023)Osteolytic bone loss and skeletal deformities in a mouse model for early-onset Paget’s disease of bone with PFN1 mutation are treatable by alendronate Pharmaceuticals (Basel). 16 1395-2
[9]
Smith JF(2011)A point mutation in the ubiquitin-associated domain of SQSMT1 is sufficient to cause a Paget’s disease-like disorder in mice Hum Mol Genet. 20 2734-8
[10]
Singer FR(2011)Detection of exon 8 mutations in sqstm1/p62 gene by mutation-specific restriction enzyme digestion: a sensitive screening for Paget disease of bone Panminerva Med. 53 71-22